People
Atara announces grant of restricted stock units and stock options under Nasdaq Listing Rule 5635(C)(4)
4 October 2021 -

T-cell immunotherapy company Atara Biotherapeutics Inc (Nasdaq:ATRA) announced on Friday that it awarded an aggregate of 104,386 restricted stock units of its common stock as well as stock options to purchase an aggregate of 107,813 shares in accordance with Nasdaq Listing Rule 5635(c)(4).

On the grant date as of 1 October 2021, 16 newly hired employees received 104,386 restricted stock units of common stock and five newly hired employees received stock options to purchase an aggregate of 107,813 shares of its common stock from the company, respectively.

Subject to the employee being continuously employment with the company, the restricted stock units vest over four years, with 25% vesting on the first quarterly vesting date after the first anniversary of the vesting commencement date and the remainder vesting in 12 approximately equal quarterly installments over the following three years.

The company added that the stock options have a ten-year term, an exercise price of USD17.50 per share and vest over four years, with 25% vesting on the first anniversary of the vesting commencement date for such employee and the remainder vesting in 36 equal monthly installments over the following three years, subject to the employee being continuously employed as of such vesting dates.

Login
Username:

Password: